Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-03

Clinical Trial Update: Prasugrel Versus Placebo in Adult Sickle Cell Disease [Phase 2]

View source ↗

Summary

Phase 2 trial comparing prasugrel with placebo in adults with sickle cell disease has completed; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRASUGREL (prasugrel)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Sickle Cell Anemia | Phase 2 | Status: COMPLETED | Results posted: 2012-05-03